Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digitalis--friend or foe?

E Erdmann1

  • 1Klinik III für Innere Medizin, Universität zu Köln, Germany.

European Heart Journal
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Cardiac glycosides offer mild positive inotropic effects and improve ejection fraction in heart failure patients, showing sustained benefits without tolerance. Their role in managing heart failure symptoms and exercise capacity is significant.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.

Internal medicine journal·2010
Same author

[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].

Deutsche medizinische Wochenschrift (1946)·2010
Same author

[Guideline based diagnosis and therapy can improve medical standards].

Deutsche medizinische Wochenschrift (1946)·2010
Same author

Pioglitazone and mechanisms of CV protection.

QJM : monthly journal of the Association of Physicians·2009
Same author

[Elevation of the ST segment and positive troponin T as a sign of myocardial damage in acute stroke].

Deutsche medizinische Wochenschrift (1946)·2009
Same author

[Preventive cardiology: from prevention to optimal patient care].

Deutsche medizinische Wochenschrift (1946)·2009

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Cardiac glycosides' therapeutic efficacy, including positive inotropic and antiarrhythmic effects, is underestimated.
  • These drugs slow resting heart rate in atrial fibrillation but do not prevent exercise-induced ventricular rate increases.

Purpose of the Study:

  • To clarify the clinical importance of digitalis glycosides' influence on heart failure mechanisms like the force-frequency relationship, preload-force relationship, and baroreceptor dysfunction.
  • To evaluate the sustained hemodynamic benefits and clinical efficacy of cardiac glycosides in heart failure.

Main Methods:

  • The abstract does not specify methods, focusing on summarizing existing knowledge and clinical observations.
  • Analysis of long-term administration effects on ejection fraction and hemodynamic parameters in heart failure patients.

Related Experiment Videos

Main Results:

  • Digitalis glycosides provide mild positive inotropic effects in heart failure without tolerance during prolonged use.
  • They persistently increase ejection fraction, leading to decreased symptoms and improved exercise capacity in congestive heart failure.
  • Current evidence suggests their therapeutic benefit is comparable to diuretics and ACE inhibitors in symptomatic heart failure.

Conclusions:

  • Cardiac glycosides demonstrate sustained positive inotropic effects and improve ejection fraction in heart failure.
  • Their clinical efficacy across different heart failure stages requires further definition, but they offer significant benefits in symptomatic cases.
  • Ongoing studies are expected to define the impact of cardiac glycosides on patient prognosis.